3 research outputs found
Synthesis of (2<i>S</i>)‑2-Chloro-2-fluororibolactone via Stereoselective Electrophilic Fluorination
A novel and efficient route for the
preparation of (2<i>S</i>)-2-chloro-2-fluorolactone <b>29</b> is described. This approach
takes advantage of a highly efficient diastereoselective electrophilic
fluorination reaction (94% yield; >50:1 dr
Fluorophosphonylated Nucleoside Derivatives as New Series of Thymidine Phosphorylase Multisubstrate Inhibitors
The synthesis of new class of potential TPase inhibitors
containing a difluoromethylphosphonate function as phosphate mimic
is reported. This new series was prepared from a readily available
fluorinated building block in few steps. Two series were evaluated
as potential inhibitors: a linear series and a conformational constrained
series. The activity of these multisubstrate inhibitors depends on
the size of the spacer introduced between the pyrimidine ring and
the phosphonate function. Best results were observed from triazolyl
derivatives, easily obtained from propargylthymine and corresponding
azides
2′-Chloro,2′-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture
Pan-genotypic
nucleoside HCV inhibitors display a high genetic
barrier to drug resistance and are the preferred direct-acting agents
to achieve complete sustained virologic response in humans. Herein,
we report, the discovery of a β-d-2′-Cl,2′-F-uridine
phosphoramidate nucleotide <b>16</b>, as a nontoxic pan-genotypic
anti-HCV agent. Phosphoramidate <b>16</b> in its 5′-triphosphate
form specifically inhibited HCV NS5B polymerase with no marked inhibition
of human polymerases and cellular mitochondrial RNA polymerase. Studies
on the intracellular half-life of phosphoramidate <b>16</b>-TP
in live cells demonstrated favorable half-life of 11.6 h, suggesting
once-a-day dosing. Stability in human blood and favorable metabolism
in human intestinal microsomes and liver microsomes make phosphoramidate <b>16</b> a prospective candidate for further studies to establish
its potential value as a new anti-HCV agent